Imperial College London

DrLukeHoward

Faculty of MedicineNational Heart & Lung Institute

Professor of Practice (Cardiopulmonary Medicine)
 
 
 
//

Contact

 

+44 (0)20 3313 3171l.howard Website

 
 
//

Location

 

B3113Hammersmith HospitalHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Frantz:2021:10.1177/20458940211057071,
author = {Frantz, RP and Benza, RL and Channick, RN and Chin, K and Howard, LS and McLaughlin, VV and Sitbon, O and Zamanian, RT and Hemnes, AR and Cravets, M and Bruey, J-M and Roscigno, R and Mottola, D and Elman, E and Zisman, LS and Ghofrani, H-A},
doi = {10.1177/20458940211057071},
journal = {PULMONARY CIRCULATION},
title = {TORREY, a Phase 2 study to evaluate the efficacy and safety of inhaled seralutinib for the treatment of pulmonary arterial hypertension},
url = {http://dx.doi.org/10.1177/20458940211057071},
volume = {11},
year = {2021}
}

RIS format (EndNote, RefMan)

TY  - JOUR
AU - Frantz,RP
AU - Benza,RL
AU - Channick,RN
AU - Chin,K
AU - Howard,LS
AU - McLaughlin,VV
AU - Sitbon,O
AU - Zamanian,RT
AU - Hemnes,AR
AU - Cravets,M
AU - Bruey,J-M
AU - Roscigno,R
AU - Mottola,D
AU - Elman,E
AU - Zisman,LS
AU - Ghofrani,H-A
DO - 10.1177/20458940211057071
PY - 2021///
SN - 2045-8932
TI - TORREY, a Phase 2 study to evaluate the efficacy and safety of inhaled seralutinib for the treatment of pulmonary arterial hypertension
T2 - PULMONARY CIRCULATION
UR - http://dx.doi.org/10.1177/20458940211057071
UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000720345200001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb
VL - 11
ER -